PTC Therapeutics, Inc. Earnings Per Share, Basic and Diluted
PTC Therapeutics, Inc. (PTCT) reported Earnings Per Share, Basic and Diluted of -$1.89 per share for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-10-28.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-10-28
- PTC Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$1.89.
- PTC Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$1.68.
- PTC Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$1.83.
- PTC Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$1.08.
- PTC Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2020 was -$6.64.
- PTC Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2019 was -$4.27.
- PTC Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2018 was -$2.75.
- PTC Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2017 was -$2.02.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|---|
| 2021-09-30 | -$1.89 10-Q · filed 2021-10-28 | -$3.57 derived: net income ÷ weighted average shares · filed 2022-10-27 | -$5.41 10-Q · filed 2021-10-28 | -$6.50 derived: net income ÷ weighted average shares · filed 2023-02-21 | |
| 2021-06-30 | -$1.68 10-Q · filed 2021-07-29 | -$3.51 10-Q · filed 2021-07-29 | -$4.60 derived: net income ÷ weighted average shares · filed 2023-02-21 | -$5.64 derived: net income ÷ weighted average shares · filed 2023-02-21 | |
| 2021-03-31 | -$1.83 10-Q · filed 2021-05-04 | -$2.92 derived: net income ÷ weighted average shares · filed 2023-02-21 | -$3.96 derived: net income ÷ weighted average shares · filed 2023-02-21 | -$6.68 derived: net income ÷ weighted average shares · filed 2023-02-21 | |
| 2020-12-31 | -$1.08 10-K · filed 2021-02-25 | -$2.11 derived: net income ÷ weighted average shares · filed 2023-02-21 | -$4.84 derived: net income ÷ weighted average shares · filed 2023-02-21 | -$6.64 10-K · filed 2021-02-25 | |
| 2020-09-30 | -$1.03 10-Q · filed 2021-10-28 | -$3.78 derived: net income ÷ weighted average shares · filed 2021-10-28 | -$5.59 10-Q · filed 2021-10-28 | -$6.87 derived: net income ÷ weighted average shares · filed 2022-02-22 | |
| 2020-06-30 | -$2.78 10-Q · filed 2021-07-29 | -$4.61 10-Q · filed 2021-07-29 | -$5.88 derived: net income ÷ weighted average shares · filed 2022-02-22 | -$7.02 derived: net income ÷ weighted average shares · filed 2022-02-22 | |
| 2020-03-31 | -$1.81 10-Q · filed 2021-05-04 | -$3.06 derived: net income ÷ weighted average shares · filed 2022-02-22 | -$4.15 derived: net income ÷ weighted average shares · filed 2022-02-22 | -$4.93 derived: net income ÷ weighted average shares · filed 2022-02-22 | |
| 2019-12-31 | -$1.37 10-K · filed 2021-02-25 | -$2.32 derived: net income ÷ weighted average shares · filed 2022-02-22 | -$3.09 derived: net income ÷ weighted average shares · filed 2022-02-22 | -$4.27 10-K · filed 2021-02-25 | |
| 2019-09-30 | -$1.06 10-K · filed 2021-02-25 | -$1.81 derived: net income ÷ weighted average shares · filed 2020-10-29 | -$3.01 10-Q · filed 2020-10-29 | -$4.07 derived: net income ÷ weighted average shares · filed 2021-02-25 | |
| 2019-06-30 | -$0.75 10-K · filed 2021-02-25 | -$1.99 10-Q · filed 2020-08-05 | -$3.00 derived: net income ÷ weighted average shares · filed 2021-02-25 | -$4.06 derived: net income ÷ weighted average shares · filed 2021-02-25 | |
| 2019-03-31 | -$1.29 10-K · filed 2021-02-25 | -$2.27 derived: net income ÷ weighted average shares · filed 2021-02-25 | -$3.33 derived: net income ÷ weighted average shares · filed 2021-02-25 | -$3.61 derived: net income ÷ weighted average shares · filed 2021-02-25 | |
| 2018-12-31 | $0.96 10-K · filed 2020-03-02 | -$0.96 10-K · filed 2019-03-01 | -$2.02 derived: net income ÷ weighted average shares · filed 2021-02-25 | -$2.26 derived: net income ÷ weighted average shares · filed 2021-02-25 | -$2.75 10-K · filed 2021-02-25 |
| 2018-09-30 | -$1.06 10-K · filed 2020-03-02 | -$1.28 derived: net income ÷ weighted average shares · filed 2019-10-30 | -$1.76 10-Q · filed 2019-10-30 | ||
| 2018-06-30 | -$0.21 10-K · filed 2020-03-02 | -$0.62 10-Q · filed 2019-08-06 | |||
| 2018-03-31 | -$0.46 10-K · filed 2020-03-02 | ||||
| 2017-12-31 | $0.03 10-K · filed 2019-03-01 | -$2.02 10-K · filed 2020-03-02 | |||
| 2017-09-30 | -$0.82 10-K · filed 2019-03-01 | -$1.27 derived: net income ÷ weighted average shares · filed 2018-11-05 | -$2.09 10-Q · filed 2018-11-05 | ||
| 2017-06-30 | -$0.44 10-K · filed 2019-03-01 | -$1.26 10-Q · filed 2018-08-07 | |||
| 2017-03-31 | -$0.85 10-K · filed 2019-03-01 | ||||
| 2016-12-31 | -$0.78 10-K · filed 2018-03-06 | -$4.17 10-K · filed 2019-03-01 | |||
| 2016-09-30 | -$1.03 10-K · filed 2018-03-06 | -$2.18 derived: net income ÷ weighted average shares · filed 2017-11-02 | -$3.39 10-Q · filed 2017-11-02 | -$4.89 derived: net income ÷ weighted average shares · filed 2018-03-06 | |
| 2016-06-30 | -$1.14 10-K · filed 2018-03-06 | -$2.36 10-Q · filed 2017-08-09 | -$3.86 derived: net income ÷ weighted average shares · filed 2018-03-06 | -$5.14 derived: net income ÷ weighted average shares · filed 2018-03-06 | |
| 2016-03-31 | -$1.22 10-K · filed 2018-03-06 | -$2.72 derived: net income ÷ weighted average shares · filed 2018-03-06 | -$3.99 derived: net income ÷ weighted average shares · filed 2018-03-06 | -$5.14 derived: net income ÷ weighted average shares · filed 2018-03-06 | |
| 2015-12-31 | -$1.50 10-K · filed 2017-03-16 | -$2.78 derived: net income ÷ weighted average shares · filed 2018-03-06 | -$3.92 derived: net income ÷ weighted average shares · filed 2018-03-06 | -$5.07 10-K · filed 2018-03-06 | |
| 2015-09-30 | -$1.27 10-K · filed 2017-03-16 | -$2.42 derived: net income ÷ weighted average shares · filed 2016-11-03 | -$3.56 10-Q · filed 2016-11-03 | -$4.15 derived: net income ÷ weighted average shares · filed 2017-03-16 | |
| 2015-06-30 | -$1.14 10-K · filed 2017-03-16 | -$2.29 10-Q · filed 2016-08-04 | -$2.89 derived: net income ÷ weighted average shares · filed 2017-03-16 | -$3.82 derived: net income ÷ weighted average shares · filed 2017-03-16 | |
| 2015-03-31 | -$1.15 10-K · filed 2017-03-16 | -$1.76 derived: net income ÷ weighted average shares · filed 2017-03-16 | -$2.68 derived: net income ÷ weighted average shares · filed 2017-03-16 | -$3.54 derived: net income ÷ weighted average shares · filed 2017-03-16 | |
| 2014-12-31 | -$0.84 10-K · filed 2016-02-29 | -$1.55 derived: net income ÷ weighted average shares · filed 2017-03-16 | -$2.40 derived: net income ÷ weighted average shares · filed 2017-03-16 | -$2.97 10-K · filed 2017-03-16 | |
| 2014-09-30 | -$0.93 10-K · filed 2016-02-29 | -$1.79 derived: net income ÷ weighted average shares · filed 2015-11-09 | -$2.34 10-Q · filed 2015-11-09 | -$3.14 derived: net income ÷ weighted average shares · filed 2016-02-29 | |
| 2014-06-30 | -$0.86 10-K · filed 2016-02-29 | -$1.40 10-Q · filed 2015-07-31 | -$2.19 derived: net income ÷ weighted average shares · filed 2016-02-29 | -$2.41 derived: net income ÷ weighted average shares · filed 2016-02-29 | |
| 2014-03-31 | -$0.58 10-K · filed 2016-02-29 | -$1.31 derived: net income ÷ weighted average shares · filed 2016-02-29 | -$1.50 derived: net income ÷ weighted average shares · filed 2016-02-29 | -$2.71 derived: net income ÷ weighted average shares · filed 2016-02-29 | |
| 2013-12-31 | -$0.74 derived: net income ÷ weighted average shares · filed 2016-02-29 | -$0.93 derived: net income ÷ weighted average shares · filed 2016-02-29 | -$2.18 derived: net income ÷ weighted average shares · filed 2016-02-29 | -$5.18 10-K · filed 2016-02-29 | |
| 2013-09-30 | -$0.19 10-Q · filed 2014-11-06 | -$1.44 derived: net income ÷ weighted average shares · filed 2014-11-06 | -$5.40 10-Q · filed 2014-11-06 | ||
| 2013-06-30 | -$5.51 10-Q · filed 2014-08-07 | -$33.26 10-Q · filed 2014-08-07 | |||
| 2013-03-31 | -$6527.30 10-Q · filed 2014-05-06 | ||||
| 2012-09-30 | -$1605.53 10-Q · filed 2013-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |